Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 1467-1473

  Browning, David J ^a   Lee, Chong ^b  

^a Nose and Throat Associates   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Hydroxychloroquine; Multifocal electroretinography; Test retest variability

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; AGE; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; COEFFICIENT OF REPEATABILITY; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FEMALE; HUMAN; MALE; MEASUREMENT; MULTIFOCAL ELECTRORETINOGRAPHY; OBSERVATIONAL STUDY; PERIMETRY; RETINA MACULA LUTEA; RETINOPATHY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SHORT TERM VARIABILITY; STATISTICAL PARAMETERS; TEST RETEST VARIABILITY; VISUAL ACUITY;

EID: 84907331734     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S66528     Document Type: Article

References (24)

1. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118(2):415-422.
2. Browning DJ. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol. 2002;133(5):649-656.
3. Browning DJ. Reply to defining ideal body weight. Am J Ophthalmol. 2002;134(6):935-936.
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310.
5. Murdoch IE, Morris SS, Cousens SN. People and eyes: statistical approaches in ophthalmology. Br J Ophthalmol. 1998;82(8):971-973.
6. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol. 2008;116(1):1-11.
7. Browning DJ. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. Am J Ophthalmol. 2013;155(3):418-428.
8. Lyons JS, Severns ML. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol. 2007;143(5):801-809.
9. Harrison WW, Bearse MA Jr, Ng JS, Barez S, Schneck ME, Adams AJ. Reproducibility of the mfERG between instruments. Doc Ophthalmol. 2009;119(1):67-78.
10. Yoshii M, Yanashima K, Wakaguri T, et al. A basic investigation of multifocal electroretinogram: reproducibility and effect of luminance. Jpn J Ophthalmol. 2000;44(2):122-127.
11. Parks S, Keating D, Evans A, Williamson TH, Lay JL, Elliott AT. Comparison of repeatability of the multifocal electroretinogram and Humphrey perimeter. Doc Ophthalmol. 1996-1997;92(4):281-289.
12. Kondo M, Miyake Y, Horiguchi M, Suzuki S, Tanikawa A. Clinical evaluation of multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1995;36(10):2146-2150.
13. Bültmann S, Rohrschneider K. Reproducibility of multifocal ERG using the scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol. 2002;240(10):841-845.
14. Penrose PJ, Tzekov RT, Sutter EE, et al. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina. 2003;23(4):503-512.
15. Grover S, Murthy RK, Brar VS, Chalam KV. Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci. 2010;51(5):2644-2647.
16. Seiple W, Vajaranant TS, Szlyk JP, et al. Multifocal electroretinography as a function of age: the importance of normative values for older adults. Invest Ophthalmol Vis Sci. 2003;44(4):1783-1792.
17. Tzekov RT, Gerth C, Werner JS. Senescence of human multifocal electroretinogram components: a localized approach. Graefes Arch Clin Exp Ophthalmol. 2004;242(7):549-560.
18. Lyons JS, Severns ML. Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review: Review of mfERG ring ratios in plaquenil toxicity. Doc Ophthalmol. 2009;118(1):29-36.
19. Marmor MF. The dilemma of hydroxychloroquine screening: new information from the multifocal ERG. Am J Ophthalmol. 2005;140(5): 894-895.
20. Bergholz R, Schroeter J, Rüther K. Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine. Br J Ophthalmol. 2010;94(12):1637-1642.
21. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130(4):461-469.
22. Lai TY, Chan WM, Li H, Lai RY, Lam DS. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol. 2005;140(5):794-807.
23. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB. A novel method for screening the multifocal electroretinogram in patients using hydroxychloroquine. Retina. 2008;28(10):1478-1486.
24. Adam MK, Covert DJ, Stepien KE, Han DP. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine toxicity. Br J Ophthalmol. 2012;96(5):723-729.